Am J Psychiatry 161:1626-1634, September 2004
© 2004 American Psychiatric Association
Prevalence and Predictors of Depression Treatment in an International Primary Care Study
Gregory E. Simon, M.D., M.P.H.,
Marcelo Fleck, M.D.,
Ramona Lucas, M.D., and
Donald M. Bushnell, M.A. LIDO Group
OBJECTIVE: The purpose of the study was to evaluate the prevalence and predictors of depression treatment in a diverse cross-national sample of primary care patients. METHOD: At primary care facilities in six countries (Spain, Israel, Australia, Brazil, Russia, and the United States), a two-stage screening process was used to identify 1,117 patients with current depressive disorder. At baseline, all patients completed a structured diagnostic interview as well as measures of anxiety symptoms, alcohol use, chronic comorbid physical conditions, and perceived barriers to treatment. Primary care physicians were advised if the research interview indicated a probable depressive disorder in their patients. Three and 9 months later, participants reported all health services (including specialty mental health care and antidepressant medication) used in the preceding 3 months. RESULTS: Across the six sites, the proportion of patients receiving any antidepressant pharmacotherapy ranged from a high of 38% in Seattle to a low of 0% in St. Petersburg; the proportion receiving any specialty mental health care varied from a high of 29% in Melbourne to a low of 3% in St. Petersburg. Patient characteristics were not consistently associated with receipt of either pharmacotherapy or specialty mental health care. Out-of-pocket cost was the most commonly reported barrier to treatment for depression; the percentage of patients who reported this barrier ranged from 24% in Barcelona to 75% in St. Petersburg. CONCLUSIONS: Depression screening and physician notification are not sufficient to prompt adequate treatment for depression. The probability of treatment may be more influenced by characteristics of health care systems than by the clinical characteristics of individual patients. Financial barriers may be more important than stigma as impediments to appropriate care.
This article has been cited by other articles:
|
|
|
|
 
I. Anderson, I. Ferrier, R. Baldwin, P. Cowen, L Howard, G Lewis, K Matthews, R. McAllister-Williams, R. Peveler, J Scott, et al.
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines
J Psychopharmacol,
June 1, 2008;
22(4):
343 - 396.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. C. Coyne and S. C. Marcus
Health Disparities in Care for Depression Possibly Obscured by the Clinical Significance Criterion
Am J Psychiatry,
September 1, 2006;
163(9):
1577 - 1579.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Colman, M. E. J. Wadsworth, T. J. Croudace, and P. B. Jones
Three decades of antidepressant, anxiolytic and hypnotic use in a national population birth cohort
The British Journal of Psychiatry,
August 1, 2006;
189(2):
156 - 160.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. BOBAK, H. PIKHART, A. PAJAK, R. KUBINOVA, S. MALYUTINA, H. SEBAKOVA, R. TOPOR-MADRY, Y. NIKITIN, and M. MARMOT
Depressive symptoms in urban population samples in Russia, Poland and the Czech Republic
The British Journal of Psychiatry,
April 1, 2006;
188(4):
359 - 365.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Fregni, P. S. Boggio, M. Nitsche, and A. Pascual-Leone
Transcranial direct current stimulation
The British Journal of Psychiatry,
May 1, 2005;
186(5):
446 - 447.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Thornicroft and D. Rose
Mental health in Europe
BMJ,
March 19, 2005;
330(7492):
613 - 614.
[Full Text]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2004
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
